178 related articles for article (PubMed ID: 29723156)
1. Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children.
García-Salido A; Melen G; Gómez-Piña V; Oñoro-Otero G; Serrano-González A; Casado-Flores J; Ramírez M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):649-654. PubMed ID: 29723156
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
4. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
[TBL] [Abstract][Full Text] [Related]
5. Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
Dettoraki A; Gil AP; Spiliotis BE
J Pediatr Endocrinol Metab; 2009 Oct; 22(10):895-904. PubMed ID: 20020577
[TBL] [Abstract][Full Text] [Related]
6. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
Ragavi R; Adole PS; Vinod KV; Pillai AA
Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
[TBL] [Abstract][Full Text] [Related]
8. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
9. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
[TBL] [Abstract][Full Text] [Related]
10. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
12. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
13. Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a.
Rahimi M; Aghabozorg Afjeh SS; Omrani MD; Arsang-Jang S; Ganji M; Noroozi R; Taheri M; Ghafouri-Fard S
Cell Physiol Biochem; 2018; 46(2):561-567. PubMed ID: 29617694
[TBL] [Abstract][Full Text] [Related]
14. Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses.
Page TH; Chiappo D; Brunini F; Garnica J; Blackburn J; Dudhiya F; Prendecki M; McAdoo SP; Pusey CD
Rheumatology (Oxford); 2022 Feb; 61(2):834-845. PubMed ID: 33974049
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
16. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
17. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging.
Scavello F; Zeni F; Tedesco CC; Mensà E; Veglia F; Procopio AD; Bonfigli AR; Olivieri F; Raucci A
Aging (Albany NY); 2019 Mar; 11(6):1648-1663. PubMed ID: 30903794
[TBL] [Abstract][Full Text] [Related]
18. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
Perkins RK; Miranda ER; Karstoft K; Beisswenger PJ; Solomon TPJ; Haus JM
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30823632
[TBL] [Abstract][Full Text] [Related]
19. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor for advanced glycation end-products (sRAGE) in childhood obesity: association with gene expression of RAGE and cardiometabolic markers.
Vega-Cárdenas M; Vargas-Morales JM; Portales-Pérez DP; Gómez-Ojeda A; Luevano-Contreras C; Aradillas-García C
Nutr Hosp; 2023 Oct; 40(5):960-966. PubMed ID: 37732356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]